TotalMarketCap

Contineum Therapeutics

CTNMNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$353.196 M

$9.00 -8.12%

Close of 6 Nov 2026

As of 6 Nov 2026, Contineum Therapeutics (CTNM) has a market capitalization of $353.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$60.0M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #211Avalo TherapeuticsAVTX$355.6M
  2. #212RezoluteRZLT$354.5M
  3. #213Contineum TherapeuticsCTNM$353.2M
  4. #214Atea PharmaceuticalsAVIR$338.9M
  5. #215Aspen NeuroscienceASPE$335.0M

What if Contineum Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$719,121.08

Per share 79,947× higher

Bitcoin $1.53T

$38,910.39

Per share 4,326× higher

Apple $5.02T

$127,739.18

Per share 14,201× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Contineum Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.